BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 7851055)

  • 1. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.
    Zhanel GG; Craig WA
    Clin Pharmacokinet; 1994 Nov; 27(5):377-92. PubMed ID: 7851055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The postantibiotic effect: a review of in vitro and in vivo data.
    Zhanel GG; Hoban DJ; Harding GK
    DICP; 1991 Feb; 25(2):153-63. PubMed ID: 2058187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The postantibiotic effect.
    Spivey JM
    Clin Pharm; 1992 Oct; 11(10):865-75. PubMed ID: 1341993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.
    Zhanel GG; Karlowsky JA; Hoban DJ; Davidson RJ
    Chemotherapy; 1991; 37(2):114-21. PubMed ID: 1903340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killing and regrowth of bacteria in vitro: a review.
    Craig WA; Ebert SC
    Scand J Infect Dis Suppl; 1990; 74():63-70. PubMed ID: 2097720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological considerations for the proper clinical use of aminoglycosides.
    Pagkalis S; Mantadakis E; Mavros MN; Ammari C; Falagas ME
    Drugs; 2011 Dec; 71(17):2277-94. PubMed ID: 22085385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantibiotic effect of aminoglycosides on gram-negative bacteria evaluated by a new method.
    Isaksson B; Nilsson L; Maller R; Sörén L
    J Antimicrob Chemother; 1988 Jul; 22(1):23-33. PubMed ID: 3139614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postantibiotic effect in Pseudomonas aeruginosa following single and multiple aminoglycoside exposures in vitro.
    Karlowsky JA; Zhanel GG; Davidson RJ; Hoban DJ
    J Antimicrob Chemother; 1994 May; 33(5):937-47. PubMed ID: 8089067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of antimicrobial therapy in surgery.
    DiPiro JT; Edmiston CE; Bohnen JM
    Am J Surg; 1996 Jun; 171(6):615-22. PubMed ID: 8678212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended dosage intervals for aminoglycosides.
    Rodman DP; Maxwell AJ; McKnight JT
    Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the evidence for once-daily aminoglycoside therapy?
    Barclay ML; Begg EJ; Hickling KG
    Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.
    Gerber AU
    Scand J Infect Dis Suppl; 1990; 74():147-54. PubMed ID: 2097702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
    Odenholt-Tornqvist I
    Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of antimicrobial activity.
    Vogelman B; Craig WA
    J Pediatr; 1986 May; 108(5 Pt 2):835-40. PubMed ID: 3701535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting duration of in-vivo postantibiotic effect for aminoglycosides against gram-negative bacilli.
    Fantin B; Ebert S; Leggett J; Vogelman B; Craig WA
    J Antimicrob Chemother; 1991 Jun; 27(6):829-36. PubMed ID: 1938689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of aminoglycosides in the intensive care unit.
    Radigan EA; Gilchrist NA; Miller MA
    J Intensive Care Med; 2010; 25(6):327-42. PubMed ID: 20837630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.